Posts by Utimize Support
ILADS Mourns the Passing of Charles Ray Jones, MD
ILADS is saddened to report the passing of pediatric Lyme specialist and long-time ILADS member, Dr. Charles Ray Jones. Dr. Jones was a legend in the Lyme community for his dedication to treating children with Lyme and tick-borne diseases. He endured harassment from the medical establishment and cared for chronically ill children at a time…
Read MoreTargeting Multicopy Prophage Genes for the Increased Detection of Borrelia burgdorferi Sensu Lato (s.l.), the Causative Agents of Lyme Disease, in Blood
The successful treatment of Lyme disease (LD) is contingent on accurate diagnosis. However, current laboratory detection assays lack sensitivity in the early stages of the disease. Because delayed diagnosis of LD incurs high healthcare costs and great suffering, new highly sensitive tests are in need. To overcome these challenges, we developed an internally controlled quantitative…
Read MoreILADS Launches Registry and Crowd-Solving Platform: One Health Lyme
Chevy Chase, MD – March 26, 2020 – The International Lyme and Associated Diseases Society (ILADS) is launching a new registry and crowd-solving platform, One Health Lyme, which will provide valuable resources to healthcare providers who are treating patients with Lyme and related diseases. In the planning stages for a while, the launch of the…
Read MoreEvidence-Based Definition of Chronic Lyme Disease Published in Antibiotics Journal
FOR IMMEDIATE RELEASE The International Lyme and Associated Diseases Society (ILADS) announced that their paper “Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group” has been published in the journal “Antibiotics” as part of the special issue “Antibiotics Resistance of Borrelia.” The authors of the paper are Dr. Samuel Shor, Dr. Christine Green,…
Read More